Patents by Inventor Joel Eisner

Joel Eisner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11980626
    Abstract: The instant invention describes pharmaceutical compositions and dosing regimens comprising seviteronel and/or dexamethasone, and methods of treating diseases, disorders or symptoms thereof.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: May 14, 2024
    Assignee: Kembi Therapeutics Pty Ltd
    Inventors: Edwina Baskin-Bey, Joel Eisner, Elizabeth Woodson
  • Publication number: 20230243813
    Abstract: Provided herein are FGFR3 activation signatures for use in methods and compositions for predicting the response of a subject suffering from cancer to FGFR3 inhibitor therapy.
    Type: Application
    Filed: June 22, 2021
    Publication date: August 3, 2023
    Inventors: Michael MILBURN, Gregory MAYHEW, Joel EISNER, Charles PEROU
  • Publication number: 20220370415
    Abstract: The instant invention describes pharmaceutical compositions and dosing regimens comprising radiation therapy and seviteronel with or without dexamethasone, and methods of treating diseases, disorders or symptoms thereof.
    Type: Application
    Filed: October 11, 2019
    Publication date: November 24, 2022
    Applicants: Kembi Therapeutics Pty Ltd, The Regents of the University of Michigan, The United States Government as represented by The Department of Veterans Affairs
    Inventors: Joel Eisner, Daniel Wahl, Corey Speers
  • Publication number: 20210154209
    Abstract: The instant invention describes pharmaceutical compositions and dosing regimens comprising seviteronel and/or dexamethasone, and methods of treating diseases, disorders or symptoms thereof.
    Type: Application
    Filed: June 5, 2020
    Publication date: May 27, 2021
    Inventors: Edwina Baskin-Bey, Joel Eisner, Elizabeth Woodson